Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anxiolytic and sedative agents. Its structure allows for selective binding to central nervous system receptors, making it valuable in creating drugs that modulate GABAergic activity. Commonly employed in the preparation of triazolopyridine derivatives with enhanced bioavailability and receptor affinity. Also utilized in research settings to explore new psychotherapeutic compounds and optimize drug candidates for improved metabolic stability.